1.Third Ventricular Chordoid Glioma: Case Report.
Sung Nam HWANG ; Seung Won PARK ; Young Baeg KIM ; Duck Young CHOI ; Mi Kyung KIM ; Shin Kwang KHANG
Journal of Korean Neurosurgical Society 2000;29(8):1103-1106
No abstract available.
Glioma*
2.KSPNO Protocol for Glioma.
Byung Kyu CHO ; Hye Lim JUNG ; Thad T GHIM ; Il Han KIM ; Yong Kil HONG ; Young Shin RA ; Mee Jeong LEE
Korean Journal of Pediatric Hematology-Oncology 2005;12(2):244-285
No abstract available.
Glioma*
3.A Case of Bilateral Thalamic Glioma Presenting with Personality Change.
Kyung Bok LEE ; Jae Ha KIM ; Ji Yoon PARK ; Hakjae ROH ; Moo Young AHN
Journal of the Korean Neurological Association 2007;25(2):278-280
No abstract available.
Glioma*
4.A Case of Nasal Glioma.
Kyun Tae KIM ; Beom Joo LEE ; Sung Ku AHN ; Seung Hun LEE ; Won Soo LEE ; Soo Im CHOI
Annals of Dermatology 1994;6(2):215-218
No abstract available.
Glioma*
5.Suprasellar Chordoid Glioma Combined with Rathke's Cleft Cyst: Case Report.
Hyun Wook LEE ; Sang Bok LEE ; Jong Hyun KIM ; Yeon Lim SUH
Journal of Korean Neurosurgical Society 2002;32(4):376-379
Chordoid glioma, a recently introduced clinicopathologic entity, is a rare neoplasm occurring mainly in the third ventricle and hypothalamus. The authors had experienced a case of chordoid glioma combined with Rathke's cleft cyst which occurred in the sellar and suparasellar region. Here we report clinical, radiological, and histopathological features of this neoplasm with review of literature
Glioma*
;
Hypothalamus
;
Third Ventricle
6.Reversible Bilateral Striatal Hypermetabolism in a Patient with Leucine-Rich Glioma Inactivated-1 Encephalitis.
Aastha TAKKAR ; Aditya CHOUDHARY ; Bhagwan RAM MITTAL ; Vivek LAL
Journal of Clinical Neurology 2016;12(4):519-520
No abstract available.
Encephalitis*
;
Glioma*
;
Humans
7.Growth Suppression by Adenovirus-mediated Gene Transfer of p16/INK4a in Glioma Cell Lines.
Mi Suk KIM ; Hee Chung KWON ; Hee Seog KANG ; In Chul PARK ; Chang Hun RHEE ; Chang Min KIM ; Choon Taek LEE ; Seok Il HONG ; Seung Hoon LEE
Journal of Korean Neurosurgical Society 2000;29(4):471-476
No abstract available.
Cell Line*
;
Glioma*
8.Clinical observation on brainstem glioma in childhood.
Hyun Jun CHO ; Se Hee HWANG ; Yong Seung HWANG ; In Won KIM
Journal of the Korean Pediatric Society 1991;34(4):532-543
No abstract available.
Brain Stem*
;
Glioma*
9.The Interaction between GFAP and Fascin in U343 Glioma Cell Line.
Dong Seok KIM ; Seung Woo PARK ; Tae Gon KIM ; Kyu Seung LEE ; Joong Uhn CHOI
Journal of Korean Neurosurgical Society 2004;35(5):507-513
No abstract available.
Cell Line*
;
Glioma*
10.Metabolic Ratio of FDG-PET and Histologic Grading in Cerebral Gliomas.
Hyung Jin SHIN ; Jong Hyun KIM ; Jung Il LEE ; Ki Joon KIM ; Tae Goo CHO ; Dong Ik SHIN ; Jong Soo KIM ; Seung Chyul HONG ; Kwan PARK ; Whan EOH ; Sun Jung KIM ; Sang Eun KIM ; Yeon Lim SUH
Journal of Korean Neurosurgical Society 1997;26(4):486-490
To assess the degree of malignancy in cerebral gliomas at the time of diagnosis, we compared the metabolic ratio using 18F-fluorodeoxyglucose(FDG)-Positron Emission Tomography(PET) with histologic grading and proliferative index(Ki-67) of cerebral gliomas. Materials for this study were histologically-examined 21 gliomas and they were divided into glioblastomas as group 1, anaplastic gliomas as group 2, and low-grade gliomas as group 3. The visual analysis of FDG-PET images showed hypermetabolic lesions in 14(87.5%) out of 16 high-grade gliomas (glioblastomas and anaplastic gliomas), and hypometabolic lesions in 4(80%) out of 5 low-grade gliomas. Tumor to cerebellum ratio(T/Cbll) in FDG-PET was used as metabolic ratio and the values of T/Cbll in each group were 1.30+/-0.10, 0.73+/-0.07, 0.70+/-0.07, respectively. In comparision of T/Cbll between group 1 with remaining two groups, differences were statistically significant(p=0.0002, p=0.0002, respectively), however, there was no statistical difference between group 2 and group 3. The values of Ki-67 were 24.16+/-5.66 in group 1, 8.10+/-2.70 in group 2, 5.46+/-1.23 in group 3, and differences were statistically significant between group 1 and group 2, 3(p=0.015, p=0.015, respectively), but there was no statistical difference between group 2 and group 3. The correlation between T/Cbll and Ki-67 was good and statistically significant(p=0.0047). In conclusion, the visual and semiquantitative analysis of FDG-PET would be helpful in determining the degree of malignancy in cerebral gliomas.
Cerebellum
;
Diagnosis
;
Glioblastoma
;
Glioma*
Result Analysis
Print
Save
E-mail